Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo

Wurzenberger, Cornelia; Kölzer, Viktor H.; Schreiber, Susanne; Anz, David; Vollmar, Angelika M.; Schnurr, Max; Endres, Stefan; Bourquin, Carole (2009). Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Cancer immunology, immunotherapy, 58(6), pp. 901-913. Springer-Verlag 10.1007/s00262-008-0606-2

Preview

Text Wurzenberger2009_Article_Short-termActivationInducesMul.pdf - Published Version Available under License Publisher holds Copyright. Download (764kB) | Preview

Dendritic cell (DC) vaccines have emerged as a promising strategy to induce antitumoral cytotoxic T cells for the immunotherapy of cancer. The maturation state of DC is of critical importance for the success of vaccination, but the most effective mode of maturation is still a matter of debate. Whereas immature DC carry the risk of inducing tolerance, extensive stimulation of DC may lead to DC unresponsiveness and exhaustion. In this study, we investigated how short-term versus long-term DC activation with a Toll-like receptor 9 agonist influences DC phenotype and function. Murine DC were generated in the presence of the hematopoietic factor Flt3L (FL-DC) to obtain both myeloid and plasmacytoid DC subsets. Short activation of FL-DC for as little as 4 h induced fully functional DC that rapidly secreted IL-12p70 and IFN-α, expressed high levels of costimulatory and MHC molecules and efficiently presented antigen to CD4 and CD8 T cells. Furthermore, short-term activated FL-DC overcame immune suppression by regulatory T cells and acquired high migratory potential toward the chemokine CCL21 necessary for DC recruitment to lymph nodes. In addition, vaccination with short-term activated DC induced a strong cytotoxic T-cell response in vivo and led to the eradication of tumors. Thus, short-term activation of DC generates fully functional DC for tumor immunotherapy. These results may guide the design of new protocols for DC generation in order to develop more efficient DC-based tumor vaccines.

Interest & Impact

Downloads

81 since deposited on 17 Oct 2018
34 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item